Trulieve Cannabis remains deeply undervalued despite recent rallies driven by political statements supporting CBD and potential cannabis reform. The MSO faces significant tax overhang due to 280E but ...
Initiating coverage on Trulieve Cannabis with a "Buy" rating, driven by potential regulatory catalysts and strong fundamentals, over a 24-month investment horizon. Florida's potential legalization of ...
TALLAHASSEE, Fla., Aug. 8, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced ...
Less than a month after short seller Grizzly Research published a report claiming that Trulieve Cannabis Corp (OTC: TCNNF) is “a fraud,” Trulieve has filed a lawsuit against Grizzly Research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback